To elucidate the mechanism underlying the protective effects of APS, we used an inhibitor of TGF-β (P144) in an in vitro study and found that following pretreatment with P144, the migration of iBMDMs and the expression of the ILK protein were both decreased. This evidence concerns the gene TGFB1 and autoimmune polyendocrinopathy.